|
1 |
Luteolin inhibits H2O2-induced cellular senescence via modulation of SIRT1 and p53
Ri Zhe Zhu, Bing Si Li, Shang Shang Gao, Jae Ho Seo, Byung-Min Choi
|
|
2 |
Prognostic Value of TP53 Mutation for Transcatheter Arterial Chemoembolization Failure/Refractoriness in HBV-Related Advanced Hepatocellular Carcinoma
Miao Xue, Yanqin Wu, Wenzhe Fan, Jian Guo, Jialiang Wei, Hongyu Wang, Jizhou Tan, Yu Wang, Wang Yao, Yue Zhao, Jiaping Li
Cancer Res Treat.2020;52(3):925-937. Published online 2020 March 30
DOI: http://dx.doi.org/10.4143/crt.2019.533
|
|
3 |
Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT
Sundong Lin, Lechu Yu, Yongqing Ni, Lulu He, Xiaolu Weng, Xuemian Lu, Chi Zhang
Diabetes Metab J.2020;44(1):158-172. Published online 2019 October 28
DOI: http://dx.doi.org/10.4093/dmj.2018.0235
|
|
4 |
Relationship between the precursors of high grade serous ovarian cancer and patient characteristics: decreased incidence of the p53 signature in pregnant women
Tsutomu Ida, Hiroyuki Fujiwara, Takahiro Kiriu, Yoshimi Taniguchi, Akira Kohyama
|
|
5 |
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim, Shin-Wha Lee, Young-Jae Lee, Ha-Young Lee, Jong-Eun Lee, Eun-Kyung Choi
|
|
6 |
Retention Esophagitis as a Significant Clinical Predictor of Progression to Esophageal Cancer in Achalasia
Haewon Kim, Hyojin Park, HeeSeung Choi, Yooju Shin, Hyunsung Park, Young Hoon Youn, Jie-Hyun Kim
Clin Endosc.2018;51(2):161-166. Published online 2018 March 6
DOI: http://dx.doi.org/10.5946/ce.2017.087
|
|
7 |
Clinical Characteristics and Prognosis of Differentiated Thyroid Carcinoma with Small Foci of Anaplastic Transformation
Hwa Young Ahn, Kyeong Choen Jung, Do Joon Park, Young Joo Park, Bo Youn Cho
|
|
8 |
Basaloid Squamous Cell Carcinoma of the Head and Neck: Subclassification into Basal, Ductal, and Mixed Subtypes Based on Comparison of Clinico-pathologic Features and Expression of p53, Cyclin D1, Epidermal Growth Factor Receptor, p16, and Human Papillomavirus
Kyung-Ja Cho, Se Un Jeong, Sung Bae Kim, Sang-wook Lee, Seung-Ho Choi, Soon Yuhl Nam, Sang Yoon Kim
|
|
9 |
Clinical Significance of p53 Protein Expression, Beta-catenin Expression and HER2 Expression for Epstein-Barr Virus-associated Gastric Cancer
Dong Won Baek, Byung Woog Kang, Soyoon Hwang, Jong Gwang Kim, An Na Seo, Han Ik Bae, Oh Kyoung Kwon, Seung Soo Lee, Ho Young Chung, Wansik Yu
|
|
10 |
Inhibition of Nicotinamide Phosphoribosyltransferase Induces Apoptosis in Estrogen Receptor-Positive MCF-7 Breast Cancer Cells
Mohammad Alaee, Shahnaz Khaghani, Kiarash Behroozfar, Zahra Hesari, Seyedeh Sara Ghorbanhosseini, Mitra Nourbakhsh
|
|
11 |
The Predictive Value of Pathologic Features in Pituitary Adenoma and Correlation with Pituitary Adenoma Recurrence
Jee Soon Kim, Youn Soo Lee, Min Jung Jung, Yong Kil Hong
|
|
12 |
Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
Ji-Yeon Kim, Kyunghee Park, Hae Hyun Jung, Eunjin Lee, Eun Yoon Cho, Kwang Hee Lee, Soo Youn Bae, Se Kyung Lee, Seok Won Kim, Jeong Eon Lee, Seok Jin Nam, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Cancer Res Treat.2016;48(4):1338-1350. Published online 2016 February 18
DOI: http://dx.doi.org/10.4143/crt.2015.430
|
|
13 |
Predictive Significance of p53, Ki-67, and Bcl-2 Expression for Pathologic Complete Response after Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer
Taeryung Kim, Wonshik Han, Min Kyoon Kim, Jun Woo Lee, Jisun Kim, Soo Kyung Ahn, Han-Byoel Lee, Hyeong-Gon Moon, Kyung-Hun Lee, Tae-Yong Kim, Sae-Won Han, Seock-Ah Im, In Ae Park, Ju-Yeon Kim, Dong-Young Noh
|
|
14 |
Ki-67 and p53 expression as a predictive marker for early postoperative recurrence in pancreatic head cancer
Hohyun Kim, Chan Yong Park, Jae Hyuk Lee, Jung Chul Kim, Chol-Kyoon Cho, Hee Jun Kim
|
|
15 |
Combined Antiangiogenic and Mammalian Target of Rapamycin Inhibitor Targeted Therapy in Metaplastic Breast Cancer Harboring a PIK3CA Mutation
Rishi Agarwal, Kimberly Koenig, Eric Rohren, Vivek Subbiah
J Breast Cancer.2014;17(3):287-290. Published online 2014 September 30
DOI: http://dx.doi.org/10.4048/jbc.2014.17.3.287
|
|
16 |
p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up
So-My Koo, Soo-taek Uh, Dong Won Kim, Ki-Up Kim, Yang-Ki Kim
|
|
17 |
Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer
Sei Hyun Ahn, Hwa Jung Kim, Wonshik Han, Jihyoung Cho, Gyungyub Gong, Kyung Hae Jung, Sung-Bae Kim, Byung Ho Son, Jong Won Lee
J Breast Cancer.2013;16(4):386-394. Published online 2013 December 31
DOI: http://dx.doi.org/10.4048/jbc.2013.16.4.386
|
|
18 |
The Blocking of c-Met Signaling Induces Apoptosis through the Increase of p53 Protein in Lung Cancer
Hae-Yun Jung, Hyun-Jung Joo, Jong Kuk Park, Yeul Hong Kim
|
|
19 |
Association of p53 Expression with Metabolic Features of Stage I Non-Small Cell Lung Cancer
Shin Myung Kang, Won-Jung Koh, Gee Young Suh, Man Pyo Chung, Joungho Han, Hojoong Kim, O Jung Kwon, Sang-Won Um
|
|
20 |
Diagnostic p53 expression in gastric endoscopic mucosal resection
Jeong Hee Cho, Im Hwan Roe, Young Joo Jin
|
|